HEPCINAT PLUS TABLET 28'S

HEPCINAT PLUS TABLET 28'S can be used in patients with kidney disease, but the dose may need to be adjusted based on the patient's kidney function. Patients with severe kidney disease may require close monitoring during treatment.

HEPCINAT PLUS TABLET 28'S can cure hepatitis C in most cases. Still, the success of the treatment depends on various factors, such as the genotype of the virus, the severity of the liver damage, and the patient's overall health.

HEPCINAT PLUS TABLET 28'S can be used in patients with HIV who also have hepatitis C. However, the treatment regimen may differ from those used for patients with hepatitis C alone, and additional monitoring may be required.

HEPCINAT PLUS TABLET 28'S can be used in patients with cirrhosis caused by hepatitis C. Still; the treatment may need to be customized based on the severity of the cirrhosis and other factors. Close monitoring is typically required for patients with cirrhosis.

HEPCINAT PLUS TABLET 28'S can be used in elderly patients. Still, the treatment plan may need to be adjusted based on factors such as kidney function, liver function, and other medical conditions. Close monitoring may be required for elderly patients during treatment.

It is important to inform your doctor about all the medications, supplements, and herbal products you are currently taking to check for potential interactions with HEPCINAT PLUS TABLET 28'S. Your doctor can provide guidance on safe co-administration.

Follow your doctor's instructions carefully. Contact your doctor immediately if you experience unusual symptoms like fever, cough, difficulty breathing, or abdominal pain. Do not stop the medication without consulting your doctor. Pregnant, breastfeeding women, elderly, and pediatric patients should use this medicine with caution and under medical supervision. Avoid close contact with infected people. Maintain a healthy diet.

HEPCINAT PLUS TABLET 28'S contains SOFOSBUVIR and DACLASTAVIR as active ingredients.

HEPCINAT PLUS TABLET 28'S is primarily used to treat chronic Hepatitis C virus (HCV) infection.

HEPCINAT PLUS TABLET 28'S contains antiviral drugs (SOFOSBUVIR and DACLASTAVIR) that directly target and inhibit the replication of the Hepatitis C virus in the body.

HEPCINAT PLUS TABLET 28'S is effective against multiple genotypes of Hepatitis C, but treatment success can vary depending on the specific genotype and other patient factors. Always consult your doctor.